Senators see possible conflicts of interest in health care pricing tools
In a statement, MultiPlan said it is working with Senate committees "to answer their questions and explain the costs and complexity patients may face" when choosing expensive care outside their networks. “We are committed to helping make healthcare transparent, fair and affordable for all,” the statement read. The commission's investigation reflects growing scrutiny of the New York-based company, which has remained largely out of the spotlight even as it has gained a dominant position in a lucrative healthcare sector. Another senator, Amy Klobuchar of Minnesota, this month asked federal antitrust authorities to investigate whether insurers and MultiPlan were conspiring to…